THC Clinical Trial
Official title:
Behavioral Pharmacology of Orally Administered THC and D-limonene
The current clinical trial will investigate the effects of orally administered d-limonene (limonene), delta-9-tetrahydrocannabinol (THC) and the combination in healthy adult volunteers.
The current clinical trial will investigate the interaction of orally administered d-limonene (limonene) and delta-9-tetrahydrocannabinol (THC). Limonene is a flavor/fragrance component common to many plants, including cannabis. The investigators have previously demonstrated that vaporized limonene can impact the acute effects of THC. The purpose of this study is to examine whether orally administered limonene modulates the acute effects of orally co-administered THC in a manner similar to when these substances are inhaled A controlled laboratory study will be completed at Johns Hopkins evaluating placebo, THC alone, and four ascending doses of d-limonene in combination with THC. Participants will be healthy adults with experience using cannabis. A total of 6 outpatient drug administration sessions will be conducted for each evaluable participant. The investigators will recruit study volunteers until 20 participants complete the protocol. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04976738 -
A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03560934 -
Tetrahydrocannabinol (THC) and Sleep
|
Early Phase 1 | |
| Not yet recruiting |
NCT05999383 -
Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration
|
Phase 2 | |
| Recruiting |
NCT04429568 -
THC Crossover Study
|
N/A | |
| Recruiting |
NCT04130633 -
Behavioral Pharmacology of THC and Alpha-pinene
|
Phase 1 | |
| Completed |
NCT05121506 -
A Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults
|
Phase 1 | |
| Completed |
NCT04360044 -
Efficacy of Inhaled Cannabis for Acute Migraine Treatment
|
Phase 2 | |
| Withdrawn |
NCT04340700 -
Characterization of the Pharmacodynamic Response to Vaped THC
|
Phase 3 | |
| Not yet recruiting |
NCT06099379 -
Modulation of THC Effects by CBD: a Dose-ranging Study
|
Phase 1/Phase 2 | |
| Completed |
NCT04851392 -
Do Adolescents and Adults Differ in Their Acute Response to Cannabis?
|
N/A | |
| Completed |
NCT04294966 -
Age-Related Effects of THC
|
Early Phase 1 | |
| Recruiting |
NCT05116527 -
THC Memory & Reward Learning Pilot
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05514899 -
Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
|
Phase 2 | |
| Not yet recruiting |
NCT03098940 -
A Bioavailability Study on Dronabinol
|
Phase 1 | |
| Active, not recruiting |
NCT02102113 -
Probing the Cannabinoid System in Individuals With a Family History of Psychosis
|
Early Phase 1 | |
| Not yet recruiting |
NCT06077292 -
Cannabis THC Potency, Metabolism, and Cognitive Impairment in Young Adults
|
N/A | |
| Suspended |
NCT05427630 -
Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment
|
Phase 2 | |
| Not yet recruiting |
NCT05641766 -
Multimodal Magnetoencephalography and Electroencephalography Exploration of the Acute Effects of THC Exposure on Neural Noise and Information Transmission Within Working Memory Networks
|
Phase 2 |